FTE Networks Announces $4 Million Corporate Stock Buyback Program
NAPLES, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) — FTE Networks, Inc. (NYSE American: FTNW) (“FTE” or the “Company”), a leading […]
Navios Maritime Containers L.P. Announces Delivery of Two Containerships; No Debt Maturities Until 2022
MONACO, Dec. 19, 2018 (GLOBE NEWSWIRE) — Navios Maritime Containers L.P. (“Navios Containers”) (NASDAQ: NMCI), a growth-oriented international owner and […]
Matinas BioPharma Appoints Harold E. Bays, M.D. to its Cardiovascular Health Scientific Advisory Board
Well known and highly regarded clinical leader having served as an Investigator for over 500 Phase 1 – 4 clinical […]
John H. Johnson Agrees to Become Permanent Chief Executive Officer of Melinta Therapeutics
NEW HAVEN, Conn., Dec. 19, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company developing and commercializing […]
New Age Brands Announces We Are Kured’s Pineapple Express CBD Vape Pen is #1 Selling Pen at Native Roots Wellness
VANCOUVER, British Columbia, Dec. 19, 2018 (GLOBE NEWSWIRE) — New Age Brands Inc. (CSE:NF) (OTC:NWGFF) (FSE:ONF) (“New Age Brands” or […]
Harvest Wins Every License Applied for in Pennsylvania
Harvest Gains Ability to Open More Retail Stores than any Other Company in the State of Pennsylvania Phoenix, Dec. 19, […]
Hemispherx Biopharma Inc. Announces First Large Ampligen Shipment to a Clinical Site for Use in U.S. Expanded Access Program
OCALA, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) — Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial […]
AgEagle to Unveil Innovative New FarmLens™ Mobile App
Feature-Rich App Delivers Mission-Critical, Intuitive and Actionable Crop Intelligence for Improving Crop Yields and Enhancing Sustainability Efforts Using Any Mobile […]
Capstone Secures 1MW Order for Global Leader in Contract Manufacturing
VAN NUYS, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) — Capstone Turbine Corporation (www.capstoneturbine.com) (Nasdaq: CPST), the world’s leading clean technology […]
InflaRx Receives European Approval to Initiate Phase II Clinical Trial with IFX-1 in ANCA-Associated Vasculitis
JENA, Germany, Dec. 19, 2018 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company developing innovative therapeutics to treat […]
